Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
QPX2014-xeruborbactam is a novel cyclic boronate beta-lactamase inhibitor that targets multiple classes of beta-lactamases, including both serine-type and metallo-beta-lactamases. It is currently being developed to combat multidrug-resistant Gram-negative bacterial infections, especially those caused by organisms like Pseudomonas aeruginosa and Carbapenem-Resistant Enterobacteriaceae / Extended-Spectrum Cephalosporin-Resistant. Xeruborbactam can restore the effecti…